Author(s): Neelesh shrivastava *,
Journal: Journal of Pharmacy Research
ISSN 0974-6943
Volume: 4;
Issue: 9;
Start page: 3063;
Date: 2011;
Original page
Keywords: Area undercurve | food and drug administration | Bioequivalence | Bioavailibility
ABSTRACT
Bioequivalence focus on the release of a drug substance from its dosage form and subsequent absorption into the systemic circulation A randomized, open label,balanced, two-treatment, two-period, two-sequence, single dose, crossover, oral bioequivalence study under fasting conditions. has been performed on omeprazolesodium carbonate 20 mg well tolerated by all subject none of the reported adverse event that could be related to subjects no one experience adverse drug reactionduring the study The study was the AUC0-t and AUCO-infinite for two treatment and two product a(test and reference) are non significant different respectively.the cmax is estimated by non parametric test non significant different .to reference. the AUC0-t and AUCO-infinite for two treatment and two product a(test andreference) are non significant different respectively. The cmax is estimated by non parametric test non significant different to reference
Journal: Journal of Pharmacy Research
ISSN 0974-6943
Volume: 4;
Issue: 9;
Start page: 3063;
Date: 2011;
Original page
Keywords: Area undercurve | food and drug administration | Bioequivalence | Bioavailibility
ABSTRACT
Bioequivalence focus on the release of a drug substance from its dosage form and subsequent absorption into the systemic circulation A randomized, open label,balanced, two-treatment, two-period, two-sequence, single dose, crossover, oral bioequivalence study under fasting conditions. has been performed on omeprazolesodium carbonate 20 mg well tolerated by all subject none of the reported adverse event that could be related to subjects no one experience adverse drug reactionduring the study The study was the AUC0-t and AUCO-infinite for two treatment and two product a(test and reference) are non significant different respectively.the cmax is estimated by non parametric test non significant different .to reference. the AUC0-t and AUCO-infinite for two treatment and two product a(test andreference) are non significant different respectively. The cmax is estimated by non parametric test non significant different to reference